Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 58.0 | 52 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 55.0 | 48 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 59.5 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 96.5 | 48 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 101.0 | 47 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 69.0 | 63 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 79.0 | 45 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 93.0 | 57 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | IL-2 | 93.5 | 48 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 53.5 | 54 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 52.0 | 48 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 53.0 | 65 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 52.5 | 64 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 47.0 | 72 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 48.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 58.0 | 43 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 76.5 | 64 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 59.0 | 58 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 79.0 | 55 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 81.0 | 66 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | IL-2 | 72.0 | 52 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-2 | 45.0 | 42 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | IL-2 | 49.5 | 56 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-2 | 51.0 | 59 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | IL-2 | 42.0 | 50 |